4DMedical Limited Stock
Stocks
4DX
AU0000095416
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
01:10:23 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 3.670 AUD | -2.65% |
|
-10.27% | -6.62% |
| 09-23 | 4DMedical Chair to Retire | MT |
| 09-23 | 4Dmedical Limited Announces CFO Changes | CI |
| Market Cap | 2.21B 1.55B 1.39B 1.28B 1.16B 2.17B 147B 15.42B 6.1B 77.23B 5.83B 5.7B 243B | P/E 2027 * |
-56.4x | P/E 2028 * | -136x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98B 1.39B 1.24B 1.15B 1.04B 1.95B 132B 13.84B 5.48B 69.34B 5.23B 5.12B 219B | EV / Sales 2027 * |
95.1x | EV / Sales 2028 * | 36.4x |
| Free-Float |
84.08% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| 4DX | Delayed | |
OTC Markets
| FDMDF | Delayed | |
|
Deutsche Boerse AG
| MQ7 | Delayed | |
|
Tradegate
| MQ7 | Real-time | |
|
Boerse Muenchen
| MQ7 | Real-time |
Last Transcript: 4DMedical Limited
| 1 day | -2.65% | ||
| 1 week | -10.27% | ||
| Current month | -13.65% | ||
| 1 month | -10.05% | ||
| 3 months | +13.27% | ||
| 6 months | -30.36% | ||
| Current year | -6.62% |
| 1 week | 3.58 |  | 4.05 |
| 1 month | 3.58 | | 4.59 |
| Current year | 2.95 | | 7.55 |
| 1 year | 1.4 | | 7.55 |
| 3 years | 0.22 | | 7.55 |
| 5 years | 0.22 | | 7.55 |
| 10 years | 0.22 | | 7.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 2012-11-30 |
Julian Sutton
DFI | Director of Finance/CFO | - | 2026-01-01 |
Greg Mogel
CTO | Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
BRD | Director/Board Member | - | 2012-11-30 |
Lilian Bianchi
CHM | Chairman | - | 2023-11-01 |
John Livingston
BRD | Director/Board Member | - | 2017-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/18/26 | Buy | Chief Financial Officer | 13,054 | 0.0022% | ||
| 3/4/26 | Exercice | Director | 213,464 | 0.0373% | ||
| 3/4/26 | Exercice | Director | 213,464 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.65% | -10.27% | +84.89% | +672.63% | 1.55B | |
| -0.40% | -2.34% | +17.82% | +45.91% | 249B | |
| +0.33% | +0.64% | +3.49% | +12.96% | 162B | |
| +1.90% | +6.00% | -17.96% | +65.92% | 157B | |
| -0.70% | +2.93% | -55.38% | -8.86% | 66.22B | |
| +0.15% | +4.09% | +10.82% | +65.55% | 52.3B | |
| +0.24% | +0.99% | -15.19% | -10.88% | 52.18B | |
| -1.13% | +2.85% | +16.39% | +28.99% | 51.34B | |
| -0.47% | +0.06% | +17.37% | +58.29% | 48.79B | |
| -0.42% | +3.83% | +27.55% | +77.45% | 44.57B | |
| Average | -0.31% | +1.01% | +8.98% | +100.80% | 88.5B | |
| Weighted average by Cap. | +0.14% | +1.48% | +1.52% | +39.52% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 20.85M 14.67M 13.1M 12.1M 10.96M 20.51M 1.39B 146M 57.65M 729M 55.04M 53.87M 2.3B | 55.1M 38.76M 34.61M 31.97M 28.97M 54.21M 3.68B 385M 152M 1.93B 145M 142M 6.08B |
| Net income | -41.1M -28.9M -25.81M -23.85M -21.61M -40.43M -2.74B -287M -114M -1.44B -108M -106M -4.53B | -16.65M -11.71M -10.46M -9.66M -8.76M -16.38M -1.11B -116M -46.04M -583M -43.96M -43.02M -1.84B |
| Net Debt | -226M -159M -142M -131M -119M -222M -15.06B -1.58B -624M -7.89B -595M -583M -24.88B | -205M -144M -129M -119M -108M -201M -13.67B -1.43B -566M -7.16B -540M -529M -22.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | A$3.670 | -2.65% | 2,202,691 |
| 26-10-22 | A$3.770 | -1.82% | 1,131,737 |
| 26-10-21 | A$3.840 | +2.95% | 2,666,615 |
| 26-10-20 | A$3.730 | -3.62% | 2,378,991 |
| 26-10-19 | A$3.870 | -5.38% | 2,477,027 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4DX Stock
Select your edition
All financial news and data tailored to specific country editions
